Minister Paris for vaccine from Pfizer-BioNTech: “An emergency approval to use is going to be requested” – National



[ad_1]

24Horas.cl Tvn

09.11.2020



This afternoon the Minister of Health, Enrique Paris referred to the results of the vaccine from the Pfizer-BioNTech laboratories, which today reported that it has an effectiveness of 90%, before which the health minister indicated that an emergency approval will be requested for use, which must be accepted in the case of Chile by the Public Health Institute (ISP).

“This vaccine has been tested in 43 thousand people, and an emergency approval to use the vaccine is going to be requested, as has also been defined in Chile (…) and this request has to be accepted in the case of Chile on ISP “, explained the minister.

“For us it is very positive news, because we have an agreement with this company, and therefore, since this vaccine claims to have this efficacy, we are very happy, it requires two doses and must be kept at a much lower temperature that what they usually use other types of vaccines, therefore the strategy and planning have to be very careful and after the second dose, a 90 degree protection has been achieved in the subjects who have received part or participated in the studies % that is achieved just 7 days after the second dose, “explained Paris.

According to the minister, Pfizer estimates that it will be able to supply 50 million doses by the end of this year and 1.3 billion doses by the end of 2021, “therefore, we are quite happy, especially since we have an agreement signed with Pfizer to access this vaccine, “he said.

Paris stated that “As the vaccine must be approved by the FDA first, then as our ISP has category 4, it can accept the approval of other agencies of the same category to apply the vaccine in Chile and it would not be necessary to do new tests in Chile to approve the vaccine “.

Piñera hopes to “start the vaccination process” in the “first months” of 2021

The President Sebastián Piñera announced that the country is in a place of “privilege and opportune” facing the process to have a vaccine against the coronavirus COVID-19, indicating that “We hope to start our vaccination program in the first months of next year.”

The President’s words are released after the vaccine created by Pfizer will report “90% efficiency” and no consequence among its volunteers, being the most advanced project so far.

In this regard, he pointed out that this “one of the vaccines with which We already have a contract and guarantee of defined provisions, Pfizer, today announced extraordinarily positive results of its clinical trials of the third phase“.

“90% Effective”: Pfizer Announces Good Results in COVID-19 Vaccine After First Trials